These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 17897917)
21. Inhibition of hepatitis C virus-transfected cholangiocarcinoma by antisense oligodeoxynucleotide in nude mice. Liu XF; Zhou XT; Zou SQ Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):115-9. PubMed ID: 14969852 [TBL] [Abstract][Full Text] [Related]
22. Enhanced RASGEF1A expression is involved in the growth and migration of intrahepatic cholangiocarcinoma. Ura K; Obama K; Satoh S; Sakai Y; Nakamura Y; Furukawa Y Clin Cancer Res; 2006 Nov; 12(22):6611-6. PubMed ID: 17121879 [TBL] [Abstract][Full Text] [Related]
23. Biological effects of RNAi targeted inhibiting Tiam1 gene expression on cholangiocarcinoma cells. Cheng W; Liu Y; Zuo Z; Yin X; Jiang B; Chen D; Peng C; Yang J Int J Clin Exp Pathol; 2015; 8(12):15511-26. PubMed ID: 26884821 [TBL] [Abstract][Full Text] [Related]
24. [Construction of a eukaryotic vector expressing E2F-1 Gene and its effect on proliferation of gastric cancer cell line MKN-45]. Wang CQ; Xiao Q; Li L; Xie YB; Tan N; Gong ZW Ai Zheng; 2007 Oct; 26(10):1064-8. PubMed ID: 17927874 [TBL] [Abstract][Full Text] [Related]
25. Induction of biliary cholangiocarcinoma cell apoptosis by 103Pd cholangial radioactive stent gamma-rays. He GJ; Sun DD; Ji DW; Sui DM; Yu FQ; Gao QY; Dai XW; Gao H; Jiang T; Dai CL Chin Med J (Engl); 2008 Jun; 121(11):1020-4. PubMed ID: 18706251 [TBL] [Abstract][Full Text] [Related]
26. Expression of CD24 in cholangiocarcinoma cells is associated with disease progression and reduced patient survival. Keeratichamroen S; Leelawat K; Thongtawee T; Narong S; Aegem U; Tujinda S; Praditphol N; Tohtong R Int J Oncol; 2011 Oct; 39(4):873-81. PubMed ID: 21687942 [TBL] [Abstract][Full Text] [Related]
27. MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression. Li J; Tian F; Li D; Chen J; Jiang P; Zheng S; Li X; Wang S FEBS Lett; 2014 Sep; 588(18):3491-500. PubMed ID: 25131931 [TBL] [Abstract][Full Text] [Related]
28. Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma. Nishino R; Honda M; Yamashita T; Takatori H; Minato H; Zen Y; Sasaki M; Takamura H; Horimoto K; Ohta T; Nakanuma Y; Kaneko S J Hepatol; 2008 Aug; 49(2):207-16. PubMed ID: 18490072 [TBL] [Abstract][Full Text] [Related]
29. High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma. Jin J; Ryu HS; Lee KB; Jang JJ PLoS One; 2014; 9(2):e90247. PubMed ID: 24587299 [TBL] [Abstract][Full Text] [Related]
30. The role of RhoC in growth and metastatic capacity of melanoma. Boone B; Van Gele M; Lambert J; Haspeslagh M; Brochez L J Cutan Pathol; 2009 Jun; 36(6):629-36. PubMed ID: 19222696 [TBL] [Abstract][Full Text] [Related]
31. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target. Sawanyawisuth K; Wongkham C; Pairojkul C; Saeseow OT; Riggins GJ; Araki N; Wongkham S Acta Oncol; 2007; 46(3):378-85. PubMed ID: 17450475 [TBL] [Abstract][Full Text] [Related]
32. [Mechanism of regulation of hepatoma cell cycle by XPD/P44 subcomplex : an in vitro experiment]. Wang HY; Xiong GF; Wu BL; Zhang JX Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1997-2001. PubMed ID: 19062744 [TBL] [Abstract][Full Text] [Related]
33. [NF-kappa B expression in cholangiocarcinoma transfected with hepatitis C virus core gene]. Liu X; Zou S; Qiu F Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):20-3. PubMed ID: 11977629 [TBL] [Abstract][Full Text] [Related]
34. [Effects of antisense 6 gene on colon cancer cells]. Zhang ZY; Xu KS; Yang GY; Wang JS; Gao Y; Liu YF; Shuai J; Wang JY; Li SY; Shou NH; Niu J Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2645-8. PubMed ID: 18162155 [TBL] [Abstract][Full Text] [Related]
35. p53 Mutations in human cholangiocarcinoma: a review. Khan SA; Thomas HC; Toledano MB; Cox IJ; Taylor-Robinson SD Liver Int; 2005 Aug; 25(4):704-16. PubMed ID: 15998419 [TBL] [Abstract][Full Text] [Related]
36. The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration. Leelawat S; Leelawat K; Narong S; Matangkasombut O Cancer Invest; 2010 May; 28(4):357-63. PubMed ID: 19916793 [TBL] [Abstract][Full Text] [Related]
37. Effects of targeting magnetic drug nanoparticles on human cholangiocarcinoma xenografts in nude mice. Tang T; Zheng JW; Chen B; Li H; Li X; Xue KY; Ai X; Zou SQ Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):303-7. PubMed ID: 17548256 [TBL] [Abstract][Full Text] [Related]
38. FHIT promotes the apoptosis of QBC939 by reducing the expression of cyclin D1. Huang Q; Xie F; Tang Z; Liu C; Wang C; Hu Y; Qiu L; Wang S; You H; Zhu K; Xu P Hepatogastroenterology; 2011; 58(107-108):713-8. PubMed ID: 21830375 [TBL] [Abstract][Full Text] [Related]
39. Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer. Feldmann G; Nattermann J; Nischalke HD; Gorschlüter M; Kuntzen T; Ahlenstiel G; Gerhardt T; Wolff M; Sauerbruch T; Spengler U; Dumoulin FL Endoscopy; 2006 Jun; 38(6):604-9. PubMed ID: 16673309 [TBL] [Abstract][Full Text] [Related]
40. mir-637 inhibits the proliferation of cholangiocarcinoma cell QBC939 through interfering CTSB expression. Li JX; Ding XM; Han S; Wang K; Jiao CY; Li XC Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1265-1276. PubMed ID: 29565483 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]